Governor Kathy Hochul today announced the completion of the $8.6 million expansion of Pine Pharmaceuticals LLC’s manufacturing facility in the city of Tonawanda. The drug outsourcing company has tripled the size of its facility at Riverview Solar Technology Park following the company’s tremendous growth over the past three years. The expansion allowed Pine to add nearly 90 new permanent full-time employees, doubling its original projections and overall permanent full-time headcount. Empire State Development has agreed to support this project with up to $650,000 in performance-based Excelsior Jobs Program tax credits.
“Manufacturing is part of New York’s heritage, and our state is home to some of the best engineers, developers, and scientists in the world,” Governor Hochul said. “Pine Pharmaceuticals’ investment in Western New York will help fill a critical need for American-made medicines, retain and create much-needed jobs, and continue to drive economic growth in our region. State.
Pine Pharmaceuticals is a family business that has experienced exponential growth and success in Western New York. The company provides pharmaceutical preparations, including specialty sterile formulations for ophthalmologists, retina specialists, hospitals, outpatient surgery centers, medical offices and clinics. The company uses state-of-the-art technology and industry-leading quality assurance practices and solves drug shortages by working with hospitals, clinics, medical offices and doctors’ offices to provide compound pharmaceuticals. sterile.
Pine Pharmaceuticals invested $8.6 million to add 50,000 square feet to the existing state-of-the-art facility. The company also benefits from low-cost power awards from the New York Power Authority: a 400 kilowatt (kW) hydro allowance in Niagara and a 136 kW ReCharge NY electricity allowance as part of its commitment to creating and retaining jobs and investing capital. Refill NY, launched by New York State in 2011, offers electricity contracts of up to seven years. Half of the power — 455 megawatts — comes from NYPA’s Niagara and St. Lawrence-Franklin D. Roosevelt hydroelectric plants, which provide the greenest, cleanest and cheapest electricity in the state. The remaining 455 megawatts is lower-cost electricity purchased by NYPA on the wholesale market.
Empire State Development President, CEO and Commissioner Hope Knight said: “The healthcare industry is a growing sector in the Western New York economy, and with Governor Hochul’s support, companies like Pine Pharmaceuticals are creating more high-quality jobs for local workers. . The company’s decision to triple the size of its facilities, while adding 40 full-time jobs, reminds us that our recovery from Covid-19 is well underway. »
Alfonse Muto, owner of Pine Pharmaceuticals, said: “We are so grateful for the support New York State has given us during our process of expansion. We are proud to lead the charge right here in Western New York creating dozens of new jobs and providing essential pharmaceuticals that will dramatically improve patient care across the country.”
The new one-story addition to the sterile preparation facility includes warehousing, quality and manufacturing space. Other significant investments include clean rooms and ISO-certified manufacturing equipment. The company will use the extra space to produce IV bags and other complex products, as well as for inspection, packaging, labeling and storage. The entire building was designed from the ground up to comply with current FDA Good Manufacturing Practices (CGMP).
State Senator Sean Ryan said: “The expansion of Pine Pharmaceuticals is a great example of how supporting the growth of local businesses helps drive our regional economy forward. I commend the company’s management team on their decision to expand operations. right here in Western New York and create dozens of new jobs for the City of Tonawanda.”
Assemblyman William Conrad said: “The nearly $9 million expansion of Pine Pharmaceuticals – which tripled the size of its facilities at the burgeoning Riverview Solar Technology Park and added 40 full-time life science jobs to our region – has been a clear symbol of Western New York’s economic resilience in the post-pandemic era. It also represents key progress for the City of Tonawanda and its strong goal to reinvent its waterfront with cleaner developments. “, greener, and more walkable. I thank Pine Pharmaceuticals for continuing to invest in Tonawanda, and I’m proud that New York State has recognized the value to all of us in partnering with this growing family business.”
Tonawanda City Supervisor Joseph Emminger said: “The expansion is a welcome addition to the continued development of Tonawanda’s business base and will add to the success of Pine Pharmaceuticals which has chosen to operate one of the premier FDA-registered outsourcing facilities in the city of Tonawanda.
Montante Construction President Douglas Elia said: “Montante Construction was proud to once again partner with Pine Pharmaceuticals for the expansion of their manufacturing facility in the Riverview Solar Technology Park. Our team came together to build a technically challenging space, including cleanrooms that limit pollutants and control environmental factors such as temperature, humidity.We look forward to future partnerships with Pine as they move forward in manufacturing high-demand medical products for healthcare practices. , clinics, hospitals and other facilities across the United States, right here in Western New York.
About Pine Pharmaceuticals
Pine Pharmaceuticals is a 503B outsourcing facility registered with the FDA and CGMP compliant. For more information, please visit www.PinePharmaceuticals.com or call 844-218-4138 to learn more about our products and services.